Biotech company Nimbus Therapeutics garners $65 mln
Cambridge, Massachusetts-based Nimbus Therapeutics, a biotechnology company, has secured $65 million in funding. The investors included Atlas Venture, SR One, Lilly Ventures, Bill Gates, Pfizer Venture Investments, Lightstone Ventures and Schrödinger.
5 June 2018•1 min read
